Exploring the spectrum of HER2 in non-metastatic triple negative breast cancer: from HER2-Null to HER2-low, including HER2-ultralow status
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Breast Cancer Treatment Studies
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Publisher
- Springer Science and Business Media LLC
- Volume
- 488
- Issue
- 3
- Pages
- 533–543
- Publication date
- 4 February 2026
- Language
- EN